Ortho Clinical Diagnostics Holdings plc (OCDX)
NASDAQ: OCDX · IEX Real-Time Price · USD
17.55
-0.18 (-1.02%)
May 25, 2022 4:00 PM EDT - Market closed
Income Statement (Annual)
Financials in millions USD. Fiscal year is February - January.
Millions USD. Fiscal year is Feb - Jan.
| Year | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|
| Revenue | 2,042.8 | 1,766.2 | 1,801.5 | 1,787.3 | 1,781.7 |
| Revenue Growth (YoY) | 15.66% | -1.96% | 0.79% | 0.31% | - |
| Cost of Revenue | 1,006.8 | 908.2 | 922.4 | 930.5 | 897.7 |
| Gross Profit | 1,036 | 858 | 879.1 | 856.8 | 884 |
| Selling, General & Admin | 555 | 489.6 | 515.1 | 491.6 | 499.8 |
| Research & Development | 126.2 | 112.9 | 98 | 98.7 | 96.4 |
| Other Operating Expenses | 180.9 | 167.2 | 180.5 | 200 | 252.5 |
| Operating Expenses | 862.1 | 769.7 | 793.6 | 790.3 | 848.7 |
| Operating Income | 173.9 | 88.3 | 85.5 | 66.5 | 35.3 |
| Interest Expense / Income | 146 | 198.2 | 231.4 | 235.6 | 239.8 |
| Other Expense / Income | 53.9 | 115.4 | 34.9 | 48.5 | -190.2 |
| Pretax Income | -26 | -225.3 | -180.8 | -217.6 | -14.3 |
| Income Tax | 28.3 | -13.4 | -23.9 | 31.2 | 102 |
| Net Income | -54.3 | -211.9 | -156.9 | -248.8 | -116.3 |
| Net Income Common | -54.3 | -211.9 | -156.9 | -248.8 | -116.3 |
| Shares Outstanding (Basic) | 228 | 146 | 146 | 145 | 91 |
| Shares Outstanding (Diluted) | 228 | 146 | 146 | 145 | 91 |
| Shares Change | 55.98% | 0.55% | 0.28% | 59.63% | - |
| EPS (Basic) | -0.24 | -1.45 | -1.08 | -1.72 | -1.28 |
| EPS (Diluted) | -0.24 | -1.45 | -1.08 | -1.72 | -1.28 |
| Free Cash Flow Per Share | 1.00 | 0.01 | 0.53 | -0.07 | -0.26 |
| Gross Margin | 50.71% | 48.58% | 48.80% | 47.94% | 49.62% |
| Operating Margin | 8.51% | 5.00% | 4.75% | 3.72% | 1.98% |
| Profit Margin | -2.66% | -12.00% | -8.71% | -13.92% | -6.53% |
| Free Cash Flow Margin | 11.17% | 0.11% | 4.26% | -0.54% | -1.32% |
| Effective Tax Rate | -108.85% | 5.95% | 13.22% | -14.34% | -713.29% |
| EBITDA | 448.1 | 298.8 | 378.1 | 350.2 | 558.8 |
| EBITDA Margin | 21.94% | 16.92% | 20.99% | 19.59% | 31.36% |
| EBIT | 120 | -27.1 | 50.6 | 18 | 225.5 |
| EBIT Margin | 5.87% | -1.53% | 2.81% | 1.01% | 12.66% |
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).